Report from London

R S Kirby

Prostate Cancer Prostatic Dis 8: 299; doi:10.1038/sj.pcan.4500850

Abstract | Full Text | PDF

Prostate News

Prostate Cancer Prostatic Dis 8: 300-303; doi:10.1038/sj.pcan.4500851

Abstract | Full Text | PDF

Impact of diet on prostate cancer: a review FREE

G A Sonn, W Aronson and M S Litwin

Prostate Cancer Prostatic Dis 8: 304-310; advance online publication, August 30, 2005; doi:10.1038/sj.pcan.4500825

Abstract | Full Text | PDF

Expectant management: an option for localized prostate cancer

M A Khan and A W Partin

Prostate Cancer Prostatic Dis 8: 311-315; advance online publication, August 30, 2005; doi:10.1038/sj.pcan.4500824

Abstract | Full Text | PDF

Hypertriglyceridemia as a possible risk factor for prostate cancer

L Wuermli, M Joerger, S Henz, H-P Schmid, W F Riesen, G Thomas, W Krek, T Cerny and S Gillessen

Prostate Cancer Prostatic Dis 8: 316-320; advance online publication, September 13, 2005; doi:10.1038/sj.pcan.4500834

Abstract | Full Text | PDF

p21 ^WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation FREE

S R J Bott, M Arya, R S Kirby and M Williamson

Prostate Cancer Prostatic Dis 8: 321-326; advance online publication, November 8, 2005; doi:10.1038/sj.pcan.4500822

Abstract | Full Text | PDF

Effects of the proteasome inhibitor bortezomib on osteolytic human prostate cancer cell metastases

P G Whang, S C Gamradt, J J Gates and J R Lieberman

Prostate Cancer Prostatic Dis 8: 327-334; advance online publication, August 30, 2005; doi:10.1038/sj.pcan.4500823

Abstract | Full Text | PDF

Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH

N Brookman-Amissah, C Duchesnes, M P Williamson, Q Wang, A Ahmed, M R Feneley, A Mackay, A Freeman, K Fenwick, M Iravani, B Weber, A Ashworth and J R Masters

Prostate Cancer Prostatic Dis 8: 335-343; advance online publication, August 30, 2005; doi:10.1038/sj.pcan.4500826

Abstract | Full Text | PDF

Extracellular matrix degrading enzymes at the prostasome surface

I Bellezza, M C Aisa, R Palazzo, E Costanzi, E Mearini and A Minelli

Prostate Cancer Prostatic Dis 8: 344-348; advance online publication, August 30, 2005; doi:10.1038/sj.pcan.4500828

Abstract | Full Text | PDF

An elevated PSA, which normalizes, does not exclude the presence of prostate cancer

J L Boddy, D J Pike, S Al-Hayek, N Shaida and P R Malone

Prostate Cancer Prostatic Dis 8: 349-352; advance online publication, July 12, 2005; doi:10.1038/sj.pcan.4500819

Abstract | Full Text | PDF

Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy

S X Cavanaugh, C D Fuller, P A Kupelian, C Reddy, P Bradshaw, B H Pollock and M Fuss

Prostate Cancer Prostatic Dis 8: 353-358; advance online publication, September 13, 2005; doi:10.1038/sj.pcan.4500831

Abstract | Full Text | PDF

Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer

Y Kinoshita, K Kuratsukuri, N Newman, P M Rovito Jr., P T P Kaumaya, C Y Wang and G P Haas

Prostate Cancer Prostatic Dis 8: 359-363; advance online publication, September 20, 2005; doi:10.1038/sj.pcan.4500835

Abstract | Full Text | PDF

Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer

J Spicer, T Plunkett, N Somaiah, S Chan, A Kendall, N Bolunwu and H Pandha

Prostate Cancer Prostatic Dis 8: 364-368; advance online publication, August 2, 2005; doi:10.1038/sj.pcan.4500821

Abstract | Full Text | PDF

Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise FREE

M Speakman, J Batista, R Berges, E Chartier-Kastler, G Conti, F Desgrandchamps, K Dreikorn, F Lowe, M O'Leary, M Perez, J Trachtenberg, A Tubaro, B Meesen, L Smets and H Stoevelaar

Prostate Cancer Prostatic Dis 8: 369-374; advance online publication, August 30, 2005; doi:10.1038/sj.pcan.4500827

Abstract | Full Text | PDF

Controlled-release doxazosin in the treatment of benign prostatic hyperplasia

C Hernandez, R Duran, J Jara, I Castaño and M Moralejo

Prostate Cancer Prostatic Dis 8: 375-380; advance online publication, November 1, 2005; doi:10.1038/sj.pcan.4500820

Abstract | Full Text | PDF

British Prostate Group Spring Meeting 11^th March 2004

Prostate Cancer Prostatic Dis 8: 381-396; doi:10.1038/sj.pcan.4500832

Abstract | Full Text | PDF